title: How does antibody combination really predict IDDM in the general population? Fortune telling--not fortune spending.
authors.affiliation: National Center For Childhood Diabetes, Schneider's Children's Medical Center, Tel-Aviv University, Israel.
authors.forename: O
authors.initials: O
authors.lastname: Pinhas-Hamiel
authors.forename: E
authors.initials: E
authors.lastname: Sprecher
authors.forename: P
authors.initials: P
authors.lastname: Vardi
mesh_terms: D001323:Autoantibodies / Q000097:blood*; D001324:Autoantigens; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis* / Q000276:immunology*; D005968:Glutamate Decarboxylase / Q000276:immunology; D006801:Humans; D007328:Insulin / Q000276:immunology; D008565:Membrane Proteins / Q000276:immunology; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1; D017027:Protein Tyrosine Phosphatases / Q000276:immunology; D054635:Receptor-Like Protein Tyrosine Phosphatases, Class 8
chemical_list: D001323:Autoantibodies; D001324:Autoantigens; D007328:Insulin; D008565:Membrane Proteins; C516862:PTPRN protein, human; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1; D017027:Protein Tyrosine Phosphatases; D054635:Receptor-Like Protein Tyrosine Phosphatases, Class 8; D005968:Glutamate Decarboxylase